Maximilian Christian Kriegmair

Prof. Dr. Maximilian Christian Kriegmair


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JMJulia Mühlbauer
Julia Mühlbauer
LELuisa Egen
Luisa Egen
KKKarl-Friedrich Kowalewski
Karl-Friedrich Kowalewski
MGMaurizio Grilli
Maurizio Grilli
MWMargarete Teresa Walach
Margarete Teresa Walach
MKMaximilian Christian Kriegmair
Maximilian Christian Kriegmair
Radiomics may increase the diagnostic accuracy of medical imaging for localized and metastatic RCC (mRCC). A systematic review and meta-analysis was performed. Doing so, we comprehensively searched literature databases until May 2020. Studies investigating the diagnostic value of radiomics in differentiation of localized renal tumors and assessment of treatment response to ST in mRCC were included and assessed with respect to their quality using the radiomics quality score (RQS). A total of 113 out of 1098 identified studies met the criteria and were included in qualitative synthesis. Median RQS of all studies was 13.9% (5.0 points, IQR 0.25–7.0 points), and RQS increased over time. Thirty studies were included into the quantitative synthesis: For distinguishing angiomyolipoma, oncocytoma or unspecified benign tumors from RCC, the random effects model showed a log odds ratio (OR) of 2.89 (95%-CI 2.40–3.39, p < 0.001), 3.08 (95%-CI 2.09–4.06, p < 0.001) and 3.57 (95%-CI 2.69–4.45, p < 0.001), respectively. For the general discrimination of benign tumors from RCC log OR was 3.17 (95%-CI 2.73–3.62, p < 0.001). Inhomogeneity of the available studies assessing treatment response in mRCC prevented any meaningful meta-analysis. The application of radiomics seems promising for discrimination of renal tumor dignity. Shared data and open science may assist in improving reproducibility of future studies.

2 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NANairveen Ali
Nairveen Ali
CBChristian Bolenz
Christian Bolenz
TTTilman Todenhöfer
Tilman Todenhöfer
ASArnulf Stenzel
Arnulf Stenzel
PDPeer Deetmar
Peer Deetmar
Thomas W. BocklitzThomas W. Bocklitz
Thomas W. Bocklitz
Bladder cancer is one of the top 10 frequently occurring cancers and leads to most cancer deaths worldwide. Recently, blue light (BL) cystoscopy-based photodynamic diagnosis was introduced as a unique technology to enhance the detection of bladder cancer, particularly for the detection of flat and small lesions. Here, we aim to demonstrate a BL image-based artificial intelligence (AI) diagnostic platform using 216 BL images, that were acquired in four different urological departments and pathologically identified with respect to cancer malignancy, invasiveness, and grading. Thereafter, four pre-trained convolution neural networks were utilized to predict image malignancy, invasiveness, and grading. The results indicated that the classification sensitivity and specificity of malignant lesions are 95.77% and 87.84%, while the mean sensitivity and mean specificity of tumor invasiveness are 88% and 96.56%, respectively. This small multicenter clinical study clearly shows the potential of AI based classification of BL images allowing for better treatment decisions and potentially higher detection rates.

1 December 2018 in European Urology Oncology
Verified
Journal Article
Closed access
MKMaximilian Christian Kriegmair
Maximilian Christian Kriegmair
Riccardo BertoloRiccardo Bertolo
Riccardo Bertolo
PKPierre I. Karakiewicz
Pierre I. Karakiewicz
BLBradley C. Leibovich
Bradley C. Leibovich
BLBorje Ljungberg
Borje Ljungberg
UCUmberto Capitanio
Umberto Capitanio

7 June 2018 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
NHNina N. Harke
Nina N. Harke
PMPhilipp Mandel
Philipp Mandel
JWJorn H. Witt
Jorn H. Witt
CWChristian Wagner
Christian Wagner
APAndrej Panic
Andrej Panic
MKMaximilian Christian Kriegmair
Maximilian Christian Kriegmair

1 April 2017 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
MKMaximilian Christian Kriegmair
Maximilian Christian Kriegmair
PMPhilipp Mandel
Philipp Mandel
AMAnett Moses
Anett Moses
JLJulia Lenk
Julia Lenk
MRMartin Rothamel
Martin Rothamel
DPDaniel Pfalzgraf
Daniel Pfalzgraf

1 May 2022 in European Urology Focus
Verified
Journal Article
Closed access
BGBritta Grüne
Britta Grüne
MKMaximilian Christian Kriegmair
Maximilian Christian Kriegmair
MLMaximilian Lenhart
Maximilian Lenhart
MMMaurice S. Michel
Maurice S. Michel
JHJohannes Huber
Johannes Huber
GAGeorg W. Alpers
Georg W. Alpers